Fig. 7From: A methylation- and immune-related lncRNA signature to predict ovarian cancer outcome and uncover mechanisms of chemoresistanceCorrelation analysis between riskcore and immune checkpoint. A, B Correlation matrix of immune checkpoints associated with ovarian cancer in training set (A) and validation set (B). C, D Correlation histogram of 6 immune checkpoints significantly related to riskscore in training set (C) and validation set (D)Back to article page